540729 — Vanta Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2019 March 31st	2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	Interim Report	ARS
Standards:	IAS	IAS	IAS	—	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	53.1	1.95	26.5	2.24	0.966
Net Total Accounts Receivable
Net Total Receivables	23.8	37.1	60.2	63.2	73.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	171	198	199	145	152
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	167	229	349	373	332
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	390	486	696	814	847
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32	98.7	148	143	177
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	168	251	457	574	672
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	222	235	239	240	175
Total Liabilities & Shareholders' Equity	390	486	696	814	847
Total Common Shares Outstanding